Small Airway Disease And Bronchial Hyperreactivity In Patients With Post Acute Covid-19 Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-01

Study Completion Date

2024-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this work is to estimate the frequency of small airway disease and/or the bronchial hyperreactivity in follow up of postacute covid survivors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Bronchiactasis as Atypical Presentation in COVID-19

NCT04910113

Covid19 in Bronchiactasis

UNKNOWN

Relationship Between Nutritional State and Respiratory Muscle Weakness in Adult Patients With Bronchietasis

NCT06002334

Bronchiectasis

UNKNOWN

Study of Bronchiectasis and Associated Cardiovascular Comorbidities

NCT05783869

Bronchiectasis

RECRUITING

Effect of Expiratory Muscle Strength in Patients With Bronchiectasis

NCT07104942

Bronchiectasis

RECRUITING

COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic

NCT04487873

Covid19 Bronchiectasis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a observational longitudinal study investigating pulmonary sequelae of covid-19.

Study site:

Mansoura university hospital, chest department and post covid outpatient clinic.

Elmahalla chest hospital and outpatients clinic.

Time of study :

Two years from September 2021 to September 2023

Target population:

Adults with confirmed covid 19 who remaining symptomatic after 30 days from the diagnosis.

Sample size The study will include 100 selected cases during period from 2021 to 2023

Patients :

The enrolled patients are adults who survived acute covid-19 and presented for clinical follow up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ambulatory adult patients confirmed diagnosis of covid -19 either on typical CT chest basis or PCR and passed period of acute illness (28 days from start of symptoms) but still with clinical symptoms.